Levent Alev

508 total citations
18 papers, 372 citations indexed

About

Levent Alev is a scholar working on Pharmacology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Levent Alev has authored 18 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 8 papers in Physiology and 8 papers in Psychiatry and Mental health. Recurrent topics in Levent Alev's work include Musculoskeletal pain and rehabilitation (13 papers), Pain Mechanisms and Treatments (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). Levent Alev is often cited by papers focused on Musculoskeletal pain and rehabilitation (13 papers), Pain Mechanisms and Treatments (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers). Levent Alev collaborates with scholars based in Japan, United States and Cyprus. Levent Alev's co-authors include Toshimitsu Ochiai, Héctor Dueñas, Shin‐ichi Konno, Hiroyuki Enomoto, Toshinaga Tsuji, Masato Murakami, Kei Ogawa, Kusuki Nishioka, William Montgomery and Yuji Uchio and has published in prestigious journals such as Spine, Arthritis Research & Therapy and Pain Medicine.

In The Last Decade

Levent Alev

18 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levent Alev Japan 11 225 181 113 97 40 18 372
Paula J. Gaynor United States 12 270 1.2× 121 0.7× 213 1.9× 90 0.9× 53 1.3× 21 493
Elena Hill United States 4 102 0.5× 239 1.3× 106 0.9× 43 0.4× 18 0.5× 6 409
Jacques Charest Canada 6 315 1.4× 121 0.7× 209 1.8× 96 1.0× 10 0.3× 8 441
Andrew Clair United States 15 299 1.3× 218 1.2× 314 2.8× 153 1.6× 16 0.4× 35 698
Jongbae J. Park United States 15 129 0.6× 57 0.3× 52 0.5× 114 1.2× 11 0.3× 23 459
Cynthia Chan Canada 8 124 0.6× 113 0.6× 89 0.8× 31 0.3× 33 0.8× 11 367
Gary W. Jay United States 10 148 0.7× 91 0.5× 247 2.2× 74 0.8× 11 0.3× 21 515
Pascal H. Vuilleumier Switzerland 12 178 0.8× 224 1.2× 73 0.6× 100 1.0× 9 0.2× 22 441
Margitta Lungenhausen Germany 8 68 0.3× 82 0.5× 163 1.4× 136 1.4× 9 0.2× 9 548
Andrew J. Holman United States 9 225 1.0× 76 0.4× 310 2.7× 142 1.5× 14 0.3× 17 515

Countries citing papers authored by Levent Alev

Since Specialization
Citations

This map shows the geographic impact of Levent Alev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Alev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Alev more than expected).

Fields of papers citing papers by Levent Alev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levent Alev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Alev. The network helps show where Levent Alev may publish in the future.

Co-authorship network of co-authors of Levent Alev

This figure shows the co-authorship network connecting the top 25 collaborators of Levent Alev. A scholar is included among the top collaborators of Levent Alev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levent Alev. Levent Alev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Konno, Shin‐ichi, et al.. (2019). An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain. Pain Medicine. 20(8). 1479–1488. 4 indexed citations
3.
Uchio, Yuji, Hiroyuki Enomoto, Levent Alev, et al.. (2018). A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. Journal of Pain Research. Volume 11. 809–821. 36 indexed citations
4.
Enomoto, Hiroyuki, Hitoshi Yasuda, Atsushi Nishiyori, et al.. (2018). Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin. Journal of Pain Research. Volume 11. 1857–1868. 14 indexed citations
5.
Satoi, Yoichi, Atsushi Kuga, Hirofumi Tokuoka, et al.. (2017). Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study. Neuropsychiatric Disease and Treatment. Volume 13. 2437–2445. 5 indexed citations
6.
Alev, Levent, et al.. (2017). Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials. Journal of Pain Research. Volume 10. 1723–1731. 16 indexed citations
7.
Enomoto, Hiroyuki, Jumpei Funai, Michael H. Ossipov, et al.. (2017). Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies. Journal of Pain Research. Volume 10. 1357–1368. 10 indexed citations
8.
Alev, Levent, et al.. (2016). Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression. Neuropsychiatric Disease and Treatment. Volume 12. 1599–1607. 14 indexed citations
9.
Vietri, Jeffrey, William Montgomery, Jing Shi, et al.. (2016). The relationship between pain severity and patient-reported outcomes among patients with chronic low back pain in Japan. Journal of Pain Research. 9. 337–337. 21 indexed citations
10.
11.
Murakami, Masato, et al.. (2016). An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia. Modern Rheumatology. 27(4). 688–695. 11 indexed citations
12.
Murakami, Masato, et al.. (2015). A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients. Arthritis Research & Therapy. 17(1). 224–224. 36 indexed citations
13.
14.
15.
Yasuda, Hitoshi, Nigishi Hotta, Masato Kasuga, et al.. (2015). Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study. Journal of Diabetes Investigation. 7(1). 100–108. 21 indexed citations
16.
17.
Dueñas, Héctor, et al.. (2013). The Role of Descending Inhibitory Pathways on Chronic Pain Modulation and Clinical Implications. Pain Practice. 14(7). 656–667. 102 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula J. Gaynor Breakdown of academic impact, for papers by Elena Hill Breakdown of academic impact, for papers by Jacques Charest Breakdown of academic impact, for papers by Andrew Clair Breakdown of academic impact, for papers by Jongbae J. Park Breakdown of academic impact, for papers by Cynthia Chan Breakdown of academic impact, for papers by Gary W. Jay Breakdown of academic impact, for papers by Pascal H. Vuilleumier Breakdown of academic impact, for papers by Margitta Lungenhausen Breakdown of academic impact, for papers by Andrew J. Holman
Rankless by CCL
2026